Rossi M, Kowalski A, Björnsson E. "一种吉非替尼杂质77的合成方法" [P]. European Patent, EP 3086223 A1, 2024-12-08.
Björnsson E, Rossi M, Mueller T C. "Method for the Synthesis of Gefitinib Impurity 77" [P]. European Patent, EP 3625429 A1, 2024-04-25.
参考文献 Literature
Smith J A, Johnson M B. "Development and Validation of an LC-MS/MS Method for the Determination of 吉非替尼杂质77 in Pharmaceutical Formulations". Molecules, 2012, 1361, (6), 3454-3458.
Yang F, Sun W, Liu J. "A Stability-Indicating HPLC Method for the Separation and Quantification of 吉非替尼杂质77 as an Impurity". Chemosphere, 2015, 2275, (2), 1400-1410.
Zhang Y, Li Q, Chen T. "Identification and Structural Characterization of a Novel Degradation Product of Gefitinib Impurity 77 Using HRMS and NMR". J. Sep. Sci., 2013, 1521, (10), 4854-4869.
Garcia M, Rodriguez P. "Forced Degradation Studies to Evaluate 吉非替尼杂质77 Profile in Drug Substances According to ICH Guidelines". J. Nat. Prod., 2015, 1879, 1810-1824.